Oncolytic therapy was first introduced in the field of oncology a decade ago. Recently, advancements have been made in oncolytic therapy, with the promise of potentially transforming the melanoma treatment landscape. In anticipation of an expanded role for oncolytic therapy, providers need updates on the mechanism of action, efficacy, safety, and practical aspects of each regimen. Advanced practice providers often spearhead the adoption of technologies such as intralesional injections in health systems. Therefore, they need up-to-date education about oncolytic therapies, opportunities to develop competency in intralesional injections, as well as support for credentialing. This curriculum, which carries the Advanced Practitioner Society for Hematology and Oncology (APSHO) Seal of Acceptance, contains didactic content on oncolytic therapies, instructional videos on techniques for intralesional injections, supportive strategies for credentialing, as well as a future opportunity for hands-on training for intralesional injections at JADPRO Live. We trust that you will find this content helpful in the adoption of an expanded role for oncolytic therapies in melanoma.
Release Date: 5/13/2025
Expiration Date: 5/12/2026
Estimated Time to Complete the Activity: 1.5 hours
Media: Interactive, text-based activity plus instructional videos
This activity is intended for oncology care providers (including physicians, advanced practice providers, nurses, pharmacists, and other healthcare providers) who care for patients with melanoma and non-melanoma skin cancer.
Upon completing this activity, the participant should be better able to:
Lisa Kottschade, APRN, MSN, CNP, FAPO
Nurse Practitioner
Associate Professor of Oncology
Mayo Clinic College of Medicine
Rochester, Minnesota
Suzanne McGettigan, MSN CRNP AOCN®
Oncology Nurse Practitioner
Senior Clinical Manager
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania Health System
Philadelphia, Pennsylvania
Margaret "Meg" Leddy, PA-C, MMSc
Physician Assistant – Oncology
Duke Cancer Center
Durham, North Carolina
APSHO is a national, non-profit, professional society with its mission to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology. APSHO believes that high-quality, cost-effective oncology patient care is best delivered through collaborative practice models that optimize the role of advanced practitioners. The APSHO Seal of Acceptance indicates that an entity bearing the seal is consistent with standards of practice and quality care while recognizing the role of the oncology/hematology advanced practitioner.
Programs and materials submitted for the APSHO Seal of Acceptance are evaluated by APSHO advanced practitioner clinical experts (that includes pharmacists, nurse practitioners, and physician assistants). They must meet all review criteria for approval, including consistency with standards of practice and quality care.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners); Terranova Medica, LLC; Advanced Practitioner Society for Hematology and Oncology (APSHO); and Integrita Healthcare Education Foundation. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Partners designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 1.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Partners designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008073-9999-25-144-H01-P
Type of Activity: Knowledge
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Lisa Kottschade, APRN, MSN, CNP, FAPO
Consultancy/Advisory Board:
Immunocore
Advisor:
Replimune
Suzanne McGettigan, MSN CRNP AOCN®
Speakers Bureau/Honoraria for non-CME:
Bristol Myers Squibb, Regeneron, Pfizer, Merck
Consultancy/Advisory Board:
Bristol Myers Squibb, Regeneron, Pfizer, Merck
Margaret "Meg" Leddy, PA-C, MMSc
Consultancy/Advisory Board:
Replimune
Lisa A. Tushla, PhD, H(ASCP) of Terranova Medica, LLC, has nothing to disclose. The APSHO, Integrita, and Partners planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Participation in this self-study activity should be completed in approximately 1.5 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from 5/13/2025 through 5/12/2026:
If you wish to receive acknowledgment for completing this activity, please follow the steps below:
Internet
To participate, you will need access to a computer (either MAC or PC), tablet, or smart phone, with a Chrome (version 22.0.1229.94 or greater) web browser, Firefox (version 3.6 or greater) web browser or an Internet Explorer (version 8.0 or greater) web browser, JavaScript enabled, connected to the Internet (high speed connection preferred).
Terranova Medica, LLC, and Partners are committed to protecting the privacy of those who choose to participate in activities on cancerce.org. The information below describes our security policies for safeguarding personal information as well as the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of personal information
Terranova Medica, LLC, and Partners do not transfer, sell, or share personal information with outside parties. We will not disclose personal information unless required in a legal proceeding.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There is no charge for this activity.
Jointly provided by Partners for Advancing Clinical Education; Terranova Medica, LLC; APSHO; and Integrita Healthcare Foundation.
This activity is supported by an independent educational grant from Replimune.
For further information, contact Tom Davis by email (tdavis@terranovamedica.com).
Copyright © 2025 Partners for Advancing Clinical Education, APSHO, Integrita, and Terranova Medica.
